查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1551769

肱骨外上髁炎治疗的全球市场

Lateral Epicondylitis Treatment
出版日期: | 出版商: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 英文 283 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

到2030年，全球肱骨外上髁炎治疗市场预计将达到112亿美元

肱骨外上髁炎治疗的全球市场预计到 2023 年将达到 95 亿美元，预计到 2030 年将达到 112 亿美元，在 2023-2030 年分析期间复合年增长率为 2.5%。非手术治疗是本报告分析的细分市场之一，预计复合年增长率为 2.9%，到分析期结束时将达到 74 亿美元。在分析期间，手术治疗领域的复合年增长率预计为 1.6%。

美国市场预计26亿美元，中国预计复合年增长率5.0%

到2023年，美国肱骨外上髁炎治疗市场预计将达到26亿美元。中国作为世界第二大经济体，预计2030年市场规模将达22亿美元，2023-2030年分析期间复合年增长率为5.0%。其他值得注意的区域市场包括日本和加拿大，在分析期间预计复合年增长率分别为 0.6% 和 1.8%。在欧洲，德国的复合年增长率预计为 1.2%。

全球肱骨外上髁炎治疗市场 - 主要趋势与驱动因素总结

什么是肱骨外上髁炎？

肱骨外上髁炎，俗称网球肘，是一种由附着在肘部外上髁上的肌腱发炎和断裂引起的疼痛性疾病。这种情况通常是由重复性压力或过度使用前臂肌肉引起的，导致肘部外侧疼痛和压痛。肱骨外上髁炎在运动员中更常见，尤其是网球运动员，但任何从事重复性手腕或手臂运动的人都可能患上外上髁炎，例如油漆工、木工和上班族。这种情况会对您执行日常生活和工作相关任务的能力产生重大影响，因此有效的治疗极为重要。如果不及时治疗，肱骨外上髁炎可能会导致慢性疼痛和残疾，这凸显了早期疗育的重要性。了解这种情况的根本原因和机制对于制定有效的治疗策略至关重要，这些策略不仅可以缓解症状，还可以解决问题的根本原因。

目前肱骨外上髁炎的治疗方法是什么？

肱骨外上髁炎的治疗包括多种旨在减轻疼痛、促进癒合和恢復功能的方法。保守治疗通常是首选，首先透过休息、使用冰敷和非类固醇消炎剂(NSAID) 来控制疼痛和发炎。物理治疗在治疗中发挥重要作用，重点是前臂肌肉的拉伸和强化练习，以减少受影响肌腱的压力。事实证明，在紧张状态下伸展肌肉的离心运动对于促进肌腱癒合特别有效。此外，手腕夹板和反力支架等矫正器具通常用于减少活动期间的压力。对于保守治疗无效的患者，可以考虑更先进的治疗，如皮质类固醇注射、富血小板血浆（PRP）治疗和衝击波治疗。这些干预措施旨在减少发炎并促进肌腱水平的组织修復。在极少数情况下，如果保守或微创治疗不成功，可能需要进行肌腱鬆解或修復等手术治疗。治疗方法的选择取决于病情的严重程度、患者的偏好以及对初始治疗的反应。

肱骨外上髁炎的治疗进展如何？

由于医疗技术的创新和持续的研究，肱骨外上髁炎的治疗方案不断发展，为难治性和重症患者带来了新的希望。最有前景的研究领域之一是再生医学，尤其是富血小板血浆（PRP）疗法。在PRP治疗中，患者自身的血小板被浓缩并注射到患处，透过释放生长因子来促进癒合。这种治疗在减轻疼痛和改善功能方面显示出有希望的结果，特别是在对其他治疗方法没有反应的慢性病例中。另一个创新领域是体外震波疗法（ESWT）的开发。 ESWT 使用声波刺激血流并促进肌腱部位的组织修復。研究表明，ESWT 是治疗方法慢性肱骨外上髁炎的有效方法，也是手术的替代治疗方法。此外，穿戴式科技的进步透过在復健运动期间提供肌肉活动和张力的即时回馈来增强肱骨外上髁炎的治疗。这些创新不仅提高了治疗效果，还缩短了復原时间并最大限度地降低了復发风险。

推动肱骨外上髁炎治疗市场成长的因素有哪些？

肱骨外上髁炎治疗市场的成长是由反映技术进步、患者人口统计变化和医疗保健实践演变的几个因素所推动的。主要因素之一是随着人口老化以及各种职业重复性压力伤害发生率的增加，包括肱骨外上髁炎的肌肉骨骼疾病的盛行率不断增加。技术进步，例如 PRP 疗法和 ESWT 等微创治疗的开发，正在扩大患者的选择范围，并促进市场成长。此外，对个人化医疗的日益关注和数位健康工具的整合正在增强肱骨外上髁炎的诊断和治疗，使治疗变得更加容易和有效。新兴市场医疗保健支出的增加和先进治疗方案的可用性增加也是推动市场扩张的主要因素。此外，患者和医疗保健提供者意识的提高强调了早期诊断和早期疗育，增加了对有效和创新治疗的需求。这些因素加上持续的研究和开发，预计将继续推动肱骨外上髁炎治疗市场的成长。

受访企业举例（共52家）

  • 3M Company
  • Aksigen Hospital Care
  • Beurer GmbH
  • BioMedical Life Systems, Inc.
  • BTL Industries
  • EMS Physio Ltd.
  • Johari Digital Healthcare Ltd.
  • OMRON Healthcare Co., Ltd.
  • Ossur hf.
  • Ottobock SE & Co. KGaA
  • Seikagaku Corporation
  • Teikoku Pharma USA
  • Zimmer Biomet Holdings, Inc.
  • Zynex, Inc.;

目录

第一章调查方法

第 2 章执行摘要

  • 市场概况
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 澳洲
  • 印度
  • 韩国
  • 其他亚太地区
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中东
  • 伊朗
  • 以色列
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 其他中东地区
  • 非洲

第四章 比赛

简介目录
Product Code: MCP26738

Global Lateral Epicondylitis Treatment Market to Reach US$11.2 Billion by 2030

The global market for Lateral Epicondylitis Treatment estimated at US$9.5 Billion in the year 2023, is expected to reach US$11.2 Billion by 2030, growing at a CAGR of 2.5% over the analysis period 2023-2030. Non-Surgical Therapies, one of the segments analyzed in the report, is expected to record a 2.9% CAGR and reach US$7.4 Billion by the end of the analysis period. Growth in the Surgical Therapies segment is estimated at 1.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.6 Billion While China is Forecast to Grow at 5.0% CAGR

The Lateral Epicondylitis Treatment market in the U.S. is estimated at US$2.6 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$2.2 Billion by the year 2030 trailing a CAGR of 5.0% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 0.6% and 1.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.2% CAGR.

Global Lateral Epicondylitis Treatment Market - Key Trends and Drivers Summarized

What Is Lateral Epicondylitis and Why Is Effective Treatment Crucial?

Lateral epicondylitis, commonly known as tennis elbow, is a painful condition resulting from inflammation or microtearing of the tendons that attach to the lateral epicondyle of the elbow. This condition is typically caused by repetitive stress or overuse of the forearm muscles, leading to pain and tenderness on the outer part of the elbow. While it is often associated with athletes, particularly tennis players, lateral epicondylitis can affect anyone who engages in repetitive wrist and arm motions, such as painters, carpenters, or office workers. The condition can significantly impact a person’s ability to perform daily activities and work-related tasks, making effective treatment crucial. Left untreated, lateral epicondylitis can lead to chronic pain and disability, underscoring the importance of early intervention. Understanding the underlying causes and mechanisms of this condition is essential for developing effective treatment strategies that not only alleviate symptoms but also address the root cause of the problem.

What Are the Current Treatment Options for Lateral Epicondylitis?

The treatment of lateral epicondylitis involves a combination of approaches aimed at reducing pain, promoting healing, and restoring function. Conservative treatment is typically the first line of defense, starting with rest, ice application, and nonsteroidal anti-inflammatory drugs (NSAIDs) to manage pain and inflammation. Physical therapy plays a crucial role in treatment, focusing on stretching and strengthening exercises for the forearm muscles to alleviate strain on the affected tendons. Eccentric exercises, where the muscle lengthens under tension, have shown particular efficacy in promoting tendon healing. Additionally, orthotic devices such as wrist splints or counterforce braces are often used to reduce strain during activities. For patients who do not respond to conservative measures, more advanced treatments like corticosteroid injections, platelet-rich plasma (PRP) therapy, or shockwave therapy may be considered. These interventions aim to reduce inflammation or stimulate tissue repair at the tendon level. In rare cases, when conservative and minimally invasive treatments fail, surgical options such as tendon release or repair may be necessary. The choice of treatment depends on the severity of the condition, patient preferences, and the response to initial therapies.

How Are Innovations and Research Advancing the Treatment of Lateral Epicondylitis?

Innovations in medical technology and ongoing research are continuously advancing the treatment options for lateral epicondylitis, offering new hope for patients with persistent or severe cases. One of the most promising areas of research is regenerative medicine, particularly the use of platelet-rich plasma (PRP) therapy. PRP involves injecting a concentrated dose of the patient’s own platelets into the affected area to promote healing through the release of growth factors. This treatment has shown encouraging results in reducing pain and improving function, particularly in chronic cases that have not responded to other therapies. Another area of innovation is the development of extracorporeal shockwave therapy (ESWT), which uses sound waves to stimulate blood flow and promote tissue repair at the tendon site. Research has demonstrated that ESWT can be an effective treatment for chronic lateral epicondylitis, offering an alternative to surgery. Additionally, advancements in wearable technology are enhancing the management of lateral epicondylitis by providing real-time feedback on muscle activity and strain during rehabilitation exercises. These innovations are not only improving the effectiveness of treatment but also reducing recovery times and minimizing the risk of recurrence.

What Factors Are Driving Growth in the Lateral Epicondylitis Treatment Market?

The growth in the lateral epicondylitis treatment market is driven by several factors that reflect technological advancements, changing patient demographics, and evolving healthcare practices. One of the primary drivers is the increasing prevalence of musculoskeletal disorders, including lateral epicondylitis, as a result of aging populations and the rising incidence of repetitive strain injuries in various professions. Technological advancements, such as the development of minimally invasive treatments like PRP therapy and ESWT, have expanded the range of options available to patients and are contributing to the market's growth. Additionally, the growing focus on personalized medicine and the integration of digital health tools are enhancing the diagnosis and management of lateral epicondylitis, making treatments more accessible and effective. The rise in healthcare expenditure and the increasing availability of advanced treatment options in emerging markets are also significant factors fueling market expansion. Furthermore, the emphasis on early diagnosis and intervention, driven by increased awareness among both patients and healthcare providers, is boosting demand for effective and innovative treatments. These factors, combined with ongoing research and development, are expected to continue driving growth in the lateral epicondylitis treatment market.

Select Competitors (Total 52 Featured) -

  • 3M Company
  • Aksigen Hospital Care
  • Beurer GmbH
  • BioMedical Life Systems, Inc.
  • BTL Industries
  • EMS Physio Ltd.
  • Johari Digital Healthcare Ltd.
  • OMRON Healthcare Co., Ltd.
  • Ossur hf.
  • Ottobock SE & Co. KGaA
  • Seikagaku Corporation
  • Teikoku Pharma USA
  • Zimmer Biomet Holdings, Inc.
  • Zynex, Inc.;

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Lateral Epicondylitis Treatment - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Incidence of Sports-Related Injuries Expands Addressable Market Opportunity for Lateral Epicondylitis Treatments
    • Advancements in Non-Surgical Therapies Propel Growth in Conservative Treatment Options for Lateral Epicondylitis
    • Increasing Adoption of Minimally Invasive Procedures Drives Demand for Innovative Lateral Epicondylitis Treatments
    • Integration of Biologic and Regenerative Medicine Throws the Spotlight on Novel Treatment Modalities for Tendon Repair
    • Emergence of Wearable and Assistive Technologies Expands Market Scope for Rehabilitation and Prevention of Lateral Epicondylitis
    • Rising Geriatric Population and Associated Tendon Degeneration Generate Demand for Long-Term Management Solutions
    • Challenges in Treatment Efficacy and Recurrence Rates Present Opportunities for Innovation in Therapeutic Approaches
    • Expansion of Sports Medicine Clinics and Physical Therapy Centers Creates New Opportunities for Lateral Epicondylitis Treatment Adoption
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Lateral Epicondylitis Treatment Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Lateral Epicondylitis Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Lateral Epicondylitis Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Non-Surgical Therapies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Non-Surgical Therapies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Non-Surgical Therapies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Surgical Therapies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Surgical Therapies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Surgical Therapies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Hospitals & Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Hospitals & Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Hospitals & Clinics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Pharma & Drug Stores End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Pharma & Drug Stores End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Pharma & Drug Stores End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Lateral Epicondylitis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 17: USA Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 18: USA Historic Review for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: USA 16-Year Perspective for Lateral Epicondylitis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Non-Surgical Therapies and Surgical Therapies for the Years 2014, 2024 & 2030
    • TABLE 20: USA Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 21: USA Historic Review for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: USA 16-Year Perspective for Lateral Epicondylitis Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 23: Canada Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 24: Canada Historic Review for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: Canada 16-Year Perspective for Lateral Epicondylitis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Non-Surgical Therapies and Surgical Therapies for the Years 2014, 2024 & 2030
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 27: Canada Historic Review for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: Canada 16-Year Perspective for Lateral Epicondylitis Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use for the Years 2014, 2024 & 2030
  • JAPAN
    • Lateral Epicondylitis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 29: Japan Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: Japan Historic Review for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: Japan 16-Year Perspective for Lateral Epicondylitis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Non-Surgical Therapies and Surgical Therapies for the Years 2014, 2024 & 2030
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Japan Historic Review for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: Japan 16-Year Perspective for Lateral Epicondylitis Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use for the Years 2014, 2024 & 2030
  • CHINA
    • Lateral Epicondylitis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 35: China Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: China Historic Review for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: China 16-Year Perspective for Lateral Epicondylitis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Non-Surgical Therapies and Surgical Therapies for the Years 2014, 2024 & 2030
    • TABLE 38: China Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: China Historic Review for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: China 16-Year Perspective for Lateral Epicondylitis Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use for the Years 2014, 2024 & 2030
  • EUROPE
    • Lateral Epicondylitis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 41: Europe Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 42: Europe Historic Review for Lateral Epicondylitis Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: Europe 16-Year Perspective for Lateral Epicondylitis Treatment by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Europe Historic Review for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: Europe 16-Year Perspective for Lateral Epicondylitis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Non-Surgical Therapies and Surgical Therapies for the Years 2014, 2024 & 2030
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for Lateral Epicondylitis Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use for the Years 2014, 2024 & 2030
  • FRANCE
    • Lateral Epicondylitis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 50: France Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: France Historic Review for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: France 16-Year Perspective for Lateral Epicondylitis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Non-Surgical Therapies and Surgical Therapies for the Years 2014, 2024 & 2030
    • TABLE 53: France Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: France Historic Review for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: France 16-Year Perspective for Lateral Epicondylitis Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use for the Years 2014, 2024 & 2030
  • GERMANY
    • Lateral Epicondylitis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 56: Germany Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Germany Historic Review for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: Germany 16-Year Perspective for Lateral Epicondylitis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Non-Surgical Therapies and Surgical Therapies for the Years 2014, 2024 & 2030
    • TABLE 59: Germany Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Germany Historic Review for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: Germany 16-Year Perspective for Lateral Epicondylitis Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 62: Italy Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Italy Historic Review for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: Italy 16-Year Perspective for Lateral Epicondylitis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Non-Surgical Therapies and Surgical Therapies for the Years 2014, 2024 & 2030
    • TABLE 65: Italy Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Italy Historic Review for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: Italy 16-Year Perspective for Lateral Epicondylitis Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Lateral Epicondylitis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 68: UK Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: UK Historic Review for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: UK 16-Year Perspective for Lateral Epicondylitis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Non-Surgical Therapies and Surgical Therapies for the Years 2014, 2024 & 2030
    • TABLE 71: UK Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: UK Historic Review for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: UK 16-Year Perspective for Lateral Epicondylitis Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 74: Spain Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Spain Historic Review for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: Spain 16-Year Perspective for Lateral Epicondylitis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Non-Surgical Therapies and Surgical Therapies for the Years 2014, 2024 & 2030
    • TABLE 77: Spain Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Spain Historic Review for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: Spain 16-Year Perspective for Lateral Epicondylitis Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 80: Russia Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Russia Historic Review for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: Russia 16-Year Perspective for Lateral Epicondylitis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Non-Surgical Therapies and Surgical Therapies for the Years 2014, 2024 & 2030
    • TABLE 83: Russia Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Russia Historic Review for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: Russia 16-Year Perspective for Lateral Epicondylitis Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 86: Rest of Europe Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Rest of Europe Historic Review for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Rest of Europe 16-Year Perspective for Lateral Epicondylitis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Non-Surgical Therapies and Surgical Therapies for the Years 2014, 2024 & 2030
    • TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Rest of Europe Historic Review for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Rest of Europe 16-Year Perspective for Lateral Epicondylitis Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Lateral Epicondylitis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 92: Asia-Pacific Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 93: Asia-Pacific Historic Review for Lateral Epicondylitis Treatment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Asia-Pacific 16-Year Perspective for Lateral Epicondylitis Treatment by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Asia-Pacific Historic Review for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Asia-Pacific 16-Year Perspective for Lateral Epicondylitis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Non-Surgical Therapies and Surgical Therapies for the Years 2014, 2024 & 2030
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Asia-Pacific 16-Year Perspective for Lateral Epicondylitis Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Lateral Epicondylitis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 101: Australia Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Australia Historic Review for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Australia 16-Year Perspective for Lateral Epicondylitis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Non-Surgical Therapies and Surgical Therapies for the Years 2014, 2024 & 2030
    • TABLE 104: Australia Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Australia Historic Review for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: Australia 16-Year Perspective for Lateral Epicondylitis Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use for the Years 2014, 2024 & 2030
  • INDIA
    • Lateral Epicondylitis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 107: India Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: India Historic Review for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: India 16-Year Perspective for Lateral Epicondylitis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Non-Surgical Therapies and Surgical Therapies for the Years 2014, 2024 & 2030
    • TABLE 110: India Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: India Historic Review for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: India 16-Year Perspective for Lateral Epicondylitis Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 113: South Korea Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 114: South Korea Historic Review for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 115: South Korea 16-Year Perspective for Lateral Epicondylitis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Non-Surgical Therapies and Surgical Therapies for the Years 2014, 2024 & 2030
    • TABLE 116: South Korea Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 117: South Korea Historic Review for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 118: South Korea 16-Year Perspective for Lateral Epicondylitis Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 119: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 120: Rest of Asia-Pacific Historic Review for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 121: Rest of Asia-Pacific 16-Year Perspective for Lateral Epicondylitis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Non-Surgical Therapies and Surgical Therapies for the Years 2014, 2024 & 2030
    • TABLE 122: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 123: Rest of Asia-Pacific Historic Review for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 124: Rest of Asia-Pacific 16-Year Perspective for Lateral Epicondylitis Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Lateral Epicondylitis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 125: Latin America Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 126: Latin America Historic Review for Lateral Epicondylitis Treatment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 127: Latin America 16-Year Perspective for Lateral Epicondylitis Treatment by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 128: Latin America Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Latin America Historic Review for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 130: Latin America 16-Year Perspective for Lateral Epicondylitis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Non-Surgical Therapies and Surgical Therapies for the Years 2014, 2024 & 2030
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 133: Latin America 16-Year Perspective for Lateral Epicondylitis Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 134: Argentina Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Argentina Historic Review for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 136: Argentina 16-Year Perspective for Lateral Epicondylitis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Non-Surgical Therapies and Surgical Therapies for the Years 2014, 2024 & 2030
    • TABLE 137: Argentina Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Argentina Historic Review for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 139: Argentina 16-Year Perspective for Lateral Epicondylitis Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 140: Brazil Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Brazil Historic Review for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 142: Brazil 16-Year Perspective for Lateral Epicondylitis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Non-Surgical Therapies and Surgical Therapies for the Years 2014, 2024 & 2030
    • TABLE 143: Brazil Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Brazil Historic Review for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 145: Brazil 16-Year Perspective for Lateral Epicondylitis Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 146: Mexico Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Mexico Historic Review for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 148: Mexico 16-Year Perspective for Lateral Epicondylitis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Non-Surgical Therapies and Surgical Therapies for the Years 2014, 2024 & 2030
    • TABLE 149: Mexico Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Mexico Historic Review for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 151: Mexico 16-Year Perspective for Lateral Epicondylitis Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 152: Rest of Latin America Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Rest of Latin America Historic Review for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 154: Rest of Latin America 16-Year Perspective for Lateral Epicondylitis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Non-Surgical Therapies and Surgical Therapies for the Years 2014, 2024 & 2030
    • TABLE 155: Rest of Latin America Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Rest of Latin America Historic Review for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 157: Rest of Latin America 16-Year Perspective for Lateral Epicondylitis Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Lateral Epicondylitis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 158: Middle East Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 159: Middle East Historic Review for Lateral Epicondylitis Treatment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 160: Middle East 16-Year Perspective for Lateral Epicondylitis Treatment by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 161: Middle East Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 162: Middle East Historic Review for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 163: Middle East 16-Year Perspective for Lateral Epicondylitis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Non-Surgical Therapies and Surgical Therapies for the Years 2014, 2024 & 2030
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 166: Middle East 16-Year Perspective for Lateral Epicondylitis Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 167: Iran Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 168: Iran Historic Review for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 169: Iran 16-Year Perspective for Lateral Epicondylitis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Non-Surgical Therapies and Surgical Therapies for the Years 2014, 2024 & 2030
    • TABLE 170: Iran Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 171: Iran Historic Review for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 172: Iran 16-Year Perspective for Lateral Epicondylitis Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 173: Israel Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 174: Israel Historic Review for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 175: Israel 16-Year Perspective for Lateral Epicondylitis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Non-Surgical Therapies and Surgical Therapies for the Years 2014, 2024 & 2030
    • TABLE 176: Israel Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 177: Israel Historic Review for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 178: Israel 16-Year Perspective for Lateral Epicondylitis Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 179: Saudi Arabia Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Saudi Arabia Historic Review for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 181: Saudi Arabia 16-Year Perspective for Lateral Epicondylitis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Non-Surgical Therapies and Surgical Therapies for the Years 2014, 2024 & 2030
    • TABLE 182: Saudi Arabia Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Saudi Arabia Historic Review for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 184: Saudi Arabia 16-Year Perspective for Lateral Epicondylitis Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 185: UAE Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 186: UAE Historic Review for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 187: UAE 16-Year Perspective for Lateral Epicondylitis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Non-Surgical Therapies and Surgical Therapies for the Years 2014, 2024 & 2030
    • TABLE 188: UAE Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 189: UAE Historic Review for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 190: UAE 16-Year Perspective for Lateral Epicondylitis Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 191: Rest of Middle East Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 192: Rest of Middle East Historic Review for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 193: Rest of Middle East 16-Year Perspective for Lateral Epicondylitis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Non-Surgical Therapies and Surgical Therapies for the Years 2014, 2024 & 2030
    • TABLE 194: Rest of Middle East Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 195: Rest of Middle East Historic Review for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 196: Rest of Middle East 16-Year Perspective for Lateral Epicondylitis Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use for the Years 2014, 2024 & 2030
  • AFRICA
    • Lateral Epicondylitis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 197: Africa Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 198: Africa Historic Review for Lateral Epicondylitis Treatment by Treatment Type - Non-Surgical Therapies and Surgical Therapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 199: Africa 16-Year Perspective for Lateral Epicondylitis Treatment by Treatment Type - Percentage Breakdown of Value Sales for Non-Surgical Therapies and Surgical Therapies for the Years 2014, 2024 & 2030
    • TABLE 200: Africa Recent Past, Current & Future Analysis for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 201: Africa Historic Review for Lateral Epicondylitis Treatment by End-Use - Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 202: Africa 16-Year Perspective for Lateral Epicondylitis Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use and Pharma & Drug Stores End-Use for the Years 2014, 2024 & 2030

IV. COMPETITION